Announcement on Key Operating Data for Q1 2025
Filed with SSE · · 3 pages · Chinese
Tasly Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Tasly Pharmaceutical
- Announcement on Resolutions of the 6th Meeting of the 9th Board of Supervisors
- Announcement on Election of Employee Director
- Announcement on Amending the "Articles of Association"
- Announcement on Resignation of Some Directors and Supervisors
- Announcement on Implementation of Annual Dividend Distribution in 2024
Later from Tasly Pharmaceutical
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on Obtaining Drug Registration Certificate for Torasemide Injection by Wholly-owned Subsidiary
- Announcement on Obtaining Drug Registration Certificate for D-Glucosamine Sulfate Capsules by Wholly-owned Subsidiary
- Announcement on Resolutions of the 10th Meeting of the 9th Board of Directors
Follow Tasly Pharmaceutical into a list and get an email when it puts out news.
Follow Tasly Pharmaceutical